Company intelligence / Profile preview

BioD Medica

Warsaw, Poland

Ownership: Private
Development stage: Other

Overview

BioD Medica is a biotechnology company focused on the development and commercialization of regenerative medicine products derived from human placental tissues. The company's product portfolio includes allografts designed to enhance wound healing and provide structural support in various surgical applications, including orthopedics, ophthalmology, and spinal surgery. By leveraging the natural healing properties of the amniotic membrane and umbilical cord, BioD Medica provides clinicians with advanced biological solutions for complex tissue repair. The company operates with a focus on high-quality processing standards to ensure the safety and efficacy of its tissue-based therapies.

Therapeutic areas: OtherNeurologyOphthalmologyDermatology
Modalities: BiologicDeviceTissue-based therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on BioD Medica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioD Medica.

Explore the full profile